CENTOGENE’s CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms Compliant With European IVD Regulatory Framework
May 25, 2022 06:30 ET | Centogene NV
CentoCloud, CENTOGENE’s cloud-based Software as a Service (SaaS) platform, is CE-marked under the In Vitro Diagnostics Directive (98/79/EC)CE-marking is required for all in vitro diagnostic (IVD)...
CENTOGENE’s CentoCloud® Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platform for Laboratories Around the World
January 04, 2022 08:00 ET | Centogene NV
The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, interpret, and report genomic variants, and will be able to...
Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc.
March 01, 2019 13:44 ET | Dawson James Securities, Inc.
BOCA RATON, Fla., March 01, 2019 (GLOBE NEWSWIRE) -- Dawson James Securities Inc. in conjunction with Precision Therapeutics Inc. (NASDAQ: AIPT) announced today the closing of its public offering of...